Stryker Corporation's Revenue by Segment
In fiscal year 2024, Stryker Corporation's revenue by segment (products & services) are as follows:
- MedSurg and Neurotechnology: $13.52 B
- Orthopaedics: $9.08 B
Learn more about Stryker Corporation’s Revenue by Geography
Check out competitors to Stryker Corporation in a side-by-side comparison.
Explore additional financial metrics for Stryker Corporation.
| MedSurg and Neurotechnology | 10611000000 |
|---|---|
| Orthopaedics | 7838000000 |
| MedSurg and Neurotechnology | 11836000000 |
|---|---|
| Orthopaedics | 8662000000 |
| MedSurg and Neurotechnology | 13518000000 |
|---|---|
| Orthopaedics | 9077000000 |
The above chart shows Stryker Corporation's revenue percentage share by segment (products and services).
In fiscal year 2022, Stryker Corporation's revenue by segment is as follows:
- MedSurg and Neurotechnology generated $10.61 B in revenue, representing 57.52% of its total revenue.
- Orthopaedics generated $7.84 B in revenue, representing 42.48% of its total revenue.
The biggest segment for Stryker Corporation is the MedSurg and Neurotechnology, which represents 57.52% of its total revenue.
The smallest segment for Stryker Corporation is the Orthopaedics, which represents 42.48% of its total revenue.
The above chart shows Stryker Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, Stryker Corporation's revenue by segment is as follows:
- MedSurg and Neurotechnology generated $11.84 B in revenue, representing 57.74% of its total revenue.
- Orthopaedics generated $8.66 B in revenue, representing 42.26% of its total revenue.
The biggest segment for Stryker Corporation is the MedSurg and Neurotechnology, which represents 57.74% of its total revenue.
The smallest segment for Stryker Corporation is the Orthopaedics, which represents 42.26% of its total revenue.
The above chart shows Stryker Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, Stryker Corporation's revenue by segment is as follows:
- MedSurg and Neurotechnology generated $13.52 B in revenue, representing 59.83% of its total revenue.
- Orthopaedics generated $9.08 B in revenue, representing 40.17% of its total revenue.
The biggest segment for Stryker Corporation is the MedSurg and Neurotechnology, which represents 59.83% of its total revenue.
The smallest segment for Stryker Corporation is the Orthopaedics, which represents 40.17% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| MedSurg and Neurotechnology | 57.52% | 57.74% | 59.83% |
| Orthopaedics | 42.48% | 42.26% | 40.17% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Stryker Corporation.
In fiscal year 2024, the MedSurg and Neurotechnology generated the most revenue ($13.52 B), and the Orthopaedics generated the least revenue ($9.08 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
